Jul 08, 2024 Labour's planning reforms for the life sciences sector By Tim Allen Hugo Kent-Egan “To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...
May 01, 2024 Highlights from the ABPI Annual Conference 2024 By Hugo Kent-Egan We enjoyed an interesting day hearing about the future of the UK life sciences industry at the ABPI Annual Conference 2024. The...
Jun 23, 2023 Stembryos: Project launched to provide guidance on research using synthetic embryo models By Hugo Kent-Egan This week a project was launched to develop the first governance framework for research involving stem cell-based embryo models (SCBEMs)...
Oct 10, 2022 UK Blood, Tissues and Cells: EU harmonisation in the works By Hugo Kent-Egan In June, the European Commission adopted the proposal for a regulation on standards of quality and safety for substances of human origin...
Sep 28, 2022 Branded medicines: time for a reset? By Hugo Kent-Egan For many years the landscape for the pricing of branded medicines in the UK was stable. This no longer appears to be the case. In recent...
May 24, 2022 HFEA considers supporting the removal of donor anonymity laws By Hugo Kent-Egan On Friday, the Guardian newspaper shared comments from Peter Thompson, chief executive of the Human Fertilisation and Embryology...
Apr 29, 2022 Updates to the Human Fertilisation and Embryology (HFE) Act By Hugo Kent-Egan On 27 April, the Progress Educational Trust (PET), a charity with the aim of advancing the public understanding of science, law and...
Apr 01, 2022 2021 Annual Report on Medicines Advertising By Hugo Kent-Egan The MHRA recently published its annual report on Delivering High Standards in Medicines Advertising Regulation. This 16th edition of the...